NASDAQ · Biotechnology

MorphoSys AG ADR (MOR)

$18.96 0.00%

Add alert

57 In band Daily RSI (14)

Moving averages

SMA 200$14.73+28.72%

Company profile

MorphoSys AG, discovers, develops and markets therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company is headquartered in Planegg, Germany.

SectorHealthcare

IndustryBiotechnology

Market cap$2.86B

P/E ratioNone

EPS$-1.50

Beta0.662

Dividend yield0.00%

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 52 VRTX Vertex Pharmaceuticals Inc RSI 64 CRSP CRISPR Therapeutics AG RSI 54 IOVA Iovance Biotherapeutics Inc RSI 66 MRNA Moderna Inc RSI 67 VKTX Viking Therapeutics Inc RSI 49 SRPT Sarepta Therapeutics Inc RSI 67 EDIT Editas Medicine Inc RSI 52 NVAX Novavax Inc RSI 72 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 44

Free forever

RSI alerts for MOR

Get an email the moment MorphoSys AG ADR crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 16 August 2026 at 3:32 AM EDT